RASP item | Usual Care (n = 29) | Intervention (n = 30) | p value |
---|---|---|---|
Prolonged use of PPI or H2RA in peptic ulcer disease | 11 | 8 | 0.412 |
Prolonged use of benzodiazepines, zolpidem, zopiclone or zaleplon | 7 | 11 | 0.399 |
Prolonged use of antidepressants | 5 | 10 | 0.233 |
Sedatives and hypnotics: benzodiazepines/zaleplon/zolpidem/zopiclone in fallers | 9 | 6 | 0.382 |
Inadequate use of inhalation therapy in patients with moderate/severe cognitive and/or functional disability | 6 | 8 | 0.761 |
Antidepressants in fallers | 8 | 5 | 0.360 |
Vitamins, minerals and trace elements without documented deficiency | 7 | 6 | 0.761 |
Additional dietary supplements without any documented need, not described in other RASP criteria (e.g. glucosamine) | 2 | 6 | 0.254 |
Venotropic drugs | 3 | 4 | 1.000 |
Antihypertensive drugs in the presence of postural hypotension | 5 | 1 | 0.103 |